Todd N. Eagar

5.4k total citations · 2 hit papers
57 papers, 3.6k citations indexed

About

Todd N. Eagar is a scholar working on Immunology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Todd N. Eagar has authored 57 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 10 papers in Molecular Biology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Todd N. Eagar's work include T-cell and B-cell Immunology (22 papers), Immunotherapy and Immune Responses (15 papers) and Multiple Sclerosis Research Studies (10 papers). Todd N. Eagar is often cited by papers focused on T-cell and B-cell Immunology (22 papers), Immunotherapy and Immune Responses (15 papers) and Multiple Sclerosis Research Studies (10 papers). Todd N. Eagar collaborates with scholars based in United States, Germany and Israel. Todd N. Eagar's co-authors include Thomas G. Forsthuber, Saisha Nalawade, Itay Raphael, Jeffrey A. Bluestone, Stephen D. Miller, Qizhi Tang, Brian T. Fife, Miyuki Azuma, Carol L. Vanderlugt and Kristen E. Pauken and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Todd N. Eagar

54 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T cell subsets and their signature cytokines in autoimmune and inflammatory diseases

2014 857 citations Itay Raphael, Saisha Nalawade et al. Cytokine profile →
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal

2009 599 citations Brian T. Fife, Todd N. Eagar et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Todd N. Eagar United States	25	2.0k	753	599	486	341	57	3.6k
Harumichi Ishigame Japan	18	3.4k 1.7×	739 1.0×	768 1.3×	632 1.3×	344 1.0×	28	4.7k
Meenu Wadhwa United Kingdom	31	2.4k 1.2×	869 1.2×	1.0k 1.7×	190 0.4×	304 0.9×	130	4.4k
Steven K. Lundy United States	33	1.8k 0.9×	505 0.7×	786 1.3×	384 0.8×	177 0.5×	59	3.5k
Carlos E. Tadokoro Brazil	20	4.1k 2.1×	741 1.0×	796 1.3×	381 0.8×	377 1.1×	45	5.4k
Caroline E. Sutton Ireland	17	2.9k 1.5×	394 0.5×	940 1.6×	311 0.6×	171 0.5×	25	4.2k
Alice Lepelley France	12	4.1k 2.1×	1.1k 1.5×	887 1.5×	386 0.8×	377 1.1×	12	5.2k
Masahito Kamanaka United States	25	3.6k 1.8×	624 0.8×	740 1.2×	317 0.7×	520 1.5×	29	5.2k
Laura M. Sly Canada	36	1.8k 0.9×	424 0.6×	1.4k 2.3×	260 0.5×	304 0.9×	63	3.5k
Mirjam Schenk United States	26	1.7k 0.8×	539 0.7×	771 1.3×	358 0.7×	215 0.6×	38	3.0k

Countries citing papers authored by Todd N. Eagar

Since Specialization

Citations

This map shows the geographic impact of Todd N. Eagar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd N. Eagar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd N. Eagar more than expected).

Fields of papers citing papers by Todd N. Eagar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd N. Eagar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd N. Eagar. The network helps show where Todd N. Eagar may publish in the future.

Co-authorship network of co-authors of Todd N. Eagar

This figure shows the co-authorship network connecting the top 25 collaborators of Todd N. Eagar. A scholar is included among the top collaborators of Todd N. Eagar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd N. Eagar. Todd N. Eagar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fida, Nadia, Todd N. Eagar, A. Rogers, et al.. (2024). Effectiveness of combined plasma cell therapy and costimulation blockade based desensitization regimen in heart transplant candidates. Clinical Transplantation. 38(2). e15249–e15249. 5 indexed citations

Knight, Richard J., Todd N. Eagar, Mark J. Hobeika, et al.. (2023). Deceased donor vein extension grafts for right living donor kidney transplantation. Clinical Transplantation. 37(8). e14963–e14963. 1 indexed citations

Huang, Howard J., Stephanie G. Yi, Constance M. Mobley, et al.. (2022). Early humoral immune response to two doses of severe acute respiratory syndrome coronavirus 2 vaccine in a diverse group of solid organ transplant candidates and recipients. Clinical Transplantation. 36(5). e14600–e14600. 9 indexed citations

Manouchehri, Navid, Rehana Z. Hussain, Petra D. Cravens, et al.. (2021). CD11c ⁺ CD88 ⁺ CD317 ⁺ myeloid cells are critical mediators of persistent CNS autoimmunity. Proceedings of the National Academy of Sciences. 118(14). 14 indexed citations

Knight, Richard J., Duc T. Nguyen, Edward A. Graviss, et al.. (2021). Long-Term Follow-Up of Renal Transplant Recipients Treated With IVIG for De Novo Donor-Specific Antibodies. Transplantation Proceedings. 53(6). 1865–1871. 1 indexed citations

Salazar, Eric, Paul Christensen, Edward A. Graviss, et al.. (2020). Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG. American Journal Of Pathology. 191(1). 90–107. 92 indexed citations

Zhao, Picheng, et al.. (2018). Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis. PLoS ONE. 13(8). e0200752–e0200752. 5 indexed citations

Eagar, Todd N., A. Osama Gaber, Samir J. Patel, et al.. (2017). The detrimental impact of persistent vs an isolated occurrence of de novo donor‐specific antibodies on intermediate‐term renal transplant outcomes. Clinical Transplantation. 31(8). 1 indexed citations

Sinha, Neeraj, J. DeVos, Thomas Kaleekal, et al.. (2017). Early clearance vs persistence of de novo donor‐specific antibodies following lung transplantation. Clinical Transplantation. 31(8). 21 indexed citations

10.

Raphael, Itay, Saisha Nalawade, Todd N. Eagar, & Thomas G. Forsthuber. (2014). T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine. 74(1). 5–17. 857 indexed citations breakdown →

11.

Monson, Nancy, Petra D. Cravens, Rehana Z. Hussain, et al.. (2011). Rituximab Therapy Reduces Organ-Specific T Cell Responses and Ameliorates Experimental Autoimmune Encephalomyelitis. PLoS ONE. 6(2). e17103–e17103. 68 indexed citations

12.

Stüve, Olaf, Bernd C. Kieseier, Bernhard Hemmer, et al.. (2010). Translational Research in Neurology and Neuroscience 2010. Archives of Neurology. 67(11). 1307–15. 13 indexed citations

13.

Martin, Maria del Pilar, Petra D. Cravens, Ryan C. Winger, et al.. (2009). Depletion of B Lymphocytes From Cerebral Perivascular Spaces by Rituximab. Archives of Neurology. 66(8). 1016–20. 69 indexed citations

14.

Singh, Mahendra Pratap, Gerd Meyer zu Hörste, Wei Hu, et al.. (2008). Quinpramine is a novel compound effective in ameliorating brain autoimmune disease. Experimental Neurology. 215(2). 397–400. 7 indexed citations

15.

Fife, Brian T., Indira Guleria, Melanie Gubbels Bupp, et al.. (2006). Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway. The Journal of Experimental Medicine. 203(12). 2737–2747. 265 indexed citations

16.

Eagar, Todd N., Danielle M. Turley, Josette Padilla, et al.. (2004). CTLA-4 Regulates Expansion and Differentiation of Th1 Cells Following Induction of Peripheral T Cell Tolerance. The Journal of Immunology. 172(12). 7442–7450. 26 indexed citations

17.

Eagar, Todd N., Qizhi Tang, Michael S. Wolfe, et al.. (2004). Notch 1 Signaling Regulates Peripheral T Cell Activation. Immunity. 20(4). 407–415. 129 indexed citations

18.

Vanderlugt, Carol L., Katherine L. Neville, Kelly M. Nikcevich, et al.. (2000). Pathologic Role and Temporal Appearance of Newly Emerging Autoepitopes in Relapsing Experimental Autoimmune Encephalomyelitis. The Journal of Immunology. 164(2). 670–678. 175 indexed citations

19.

Karandikar, Nitin J., Carol L. Vanderlugt, Todd N. Eagar, et al.. (1998). Tissue-Specific Up-Regulation of B7-1 Expression and Function During the Course of Murine Relapsing Experimental Autoimmune Encephalomyelitis. The Journal of Immunology. 161(1). 192–199. 57 indexed citations

20.

Vanderlugt, Carol L., Wendy Smith Begolka, Katherine L. Neville, et al.. (1998). The functional significance of epitope spreading and its regulation by co‐stimulatory molecules. Immunological Reviews. 164(1). 63–72. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact